Operating Segment Information (Tables)

9 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(Dollars in thousands)	2015			2014			2015			2014
Revenue:
Medical Device	$	11,629		$	10,821		$	32,827		$	31,852
In Vitro Diagnostics		4,285			3,795			11,708			10,251
Total revenue	$	15,914		$	14,616		$	44,535		$	42,103
Operating income:
Medical Device	$	6,295		$	5,855		$	16,507		$	16,466
In Vitro Diagnostics		1,191			974			3,220			2,277
Total segment operating income		7,486			6,829			19,727			18,743
Corporate		(1,629	)		(1,496	)		(4,903	)		(5,601	)
Total operating income	$	5,857		$	5,333		$	14,824		$	13,142
Depreciation and amortization:
Medical Device	$	288		$	281		$	852		$	862
In Vitro Diagnostics		215			214			645			641
Corporate		191			179			586			551
Total depreciation and amortization	$	694		$	674		$	2,083		$	2,054